Vincerx Pharma Correlations

VINC Stock

USD 0.65 0.03 4.84%

The current 90-days correlation between Vincerx Pharma and Bolt Biotherapeutics is 0.35 (i.e., Weak diversification). The correlation of Vincerx Pharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Vincerx Pharma Correlation With Market

Good diversification

The correlation between Vincerx Pharma and DJI is -0.12 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Vincerx Pharma and DJI in the same portfolio, assuming nothing else is changed.

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vincerx Pharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

For information on how to trade Vincerx Stock refer to our How to Trade Vincerx Stock guide.

Moving together with Vincerx Stock

0.94	EYEN	Eyenovia	Pair Corr
0.81	CLDX	Celldex Therapeutics	Pair Corr
0.86	CRNX	Crinetics Pharmaceuticals	Pair Corr
0.73	MDAI	Spectral AI	Pair Corr
0.8	MODD	Modular Medical	Pair Corr
0.76	APYX	Apyx Medical	Pair Corr
0.88	SGHT	Sight Sciences	Pair Corr
0.85	SRDX	SurModics	Pair Corr
0.65	CNMD	CONMED	Pair Corr

Moving against Vincerx Stock

0.93	FNA	Paragon 28	Pair Corr
0.79	CPIX	Cumberland Pharmaceuticals Downward Rally	Pair Corr
0.69	CMRX	Chimerix	Pair Corr
0.48	OPT	Opthea	Pair Corr
0.95	NVRO	Nevro Corp	Pair Corr
0.8	LUCD	Lucid Diagnostics	Pair Corr
0.75	NYXH	Nyxoah	Pair Corr
0.72	INMD	InMode	Pair Corr
0.5	LUNG	Pulmonx Corp	Pair Corr
0.43	MASI	Masimo	Pair Corr
0.4	KIDS	Orthopediatrics Corp	Pair Corr
0.85	TOI	Oncology Institute Earnings Call This Week	Pair Corr
0.82	BRK-A	Berkshire Hathaway	Pair Corr
0.82	BRK-B	Berkshire Hathaway	Pair Corr
0.76	FWEDF	Fireweed Zinc	Pair Corr
0.67	TMCI	Treace Medical Concepts	Pair Corr
0.62	SWZNF	Schweizerische Nationalbank	Pair Corr

Related Correlations Analysis

	SPRO	BOLT	CHRS	GRCL	NLTX	APLT	LYRA	STTK	BCAB	MNPR
SPRO		0.83	0.52	0.0	0.0	0.51	0.28	-0.24	0.77	-0.56	SPRO
BOLT	0.83		0.73	0.0	0.0	0.62	0.55	-0.09	0.47	-0.32	BOLT
CHRS	0.52	0.73		0.0	0.0	0.86	0.42	-0.04	-0.03	-0.36	CHRS
GRCL	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	GRCL
NLTX	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	NLTX
APLT	0.51	0.62	0.86	0.0	0.0		0.3	-0.16	0.06	-0.41	APLT
LYRA	0.28	0.55	0.42	0.0	0.0	0.3		0.4	-0.07	-0.06	LYRA
STTK	-0.24	-0.09	-0.04	0.0	0.0	-0.16	0.4		-0.33	0.1	STTK
BCAB	0.77	0.47	-0.03	0.0	0.0	0.06	-0.07	-0.33		-0.35	BCAB
MNPR	-0.56	-0.32	-0.36	0.0	0.0	-0.41	-0.06	0.1	-0.35		MNPR
	SPRO	BOLT	CHRS	GRCL	NLTX	APLT	LYRA	STTK	BCAB	MNPR

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

APLT	+ 0.86	CHRS
BOLT	+ 0.83	SPRO
BCAB	+ 0.77	SPRO
CHRS	+ 0.73	BOLT
APLT	+ 0.62	BOLT
LYRA	+ 0.55	BOLT

High negative correlations

MNPR	- 0.56	SPRO
MNPR	- 0.41	APLT
MNPR	- 0.36	CHRS
MNPR	- 0.35	BCAB
BCAB	- 0.33	STTK
MNPR	- 0.32	BOLT

Risk-Adjusted Indicators

There is a big difference between Vincerx Stock performing well and Vincerx Pharma Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Vincerx Pharma's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
SPRO	2.57	(0.56)	0.00	3.53	0.00	0.00	4.85	(6.25)	21.98
BOLT	2.62	(0.22)	0.00	(1.22)	0.00	0.00	5.08	(6.45)	17.46
CHRS	3.76	(0.66)	0.00	0.45	0.00	0.00	7.48	(8.00)	31.16
GRCL	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NLTX	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
APLT	4.50	(0.88)	0.00	0.56	0.00	0.00	9.26	(8.75)	24.53
LYRA	2.97	(0.14)	0.00	(0.51)	0.00	0.00	5.88	(5.88)	25.31
STTK	5.20	0.25	0.04	0.29	6.38	(6.57)	11.21	(7.58)	50.15
BCAB	5.39	(1.59)	0.00	(0.87)	0.00	0.00	6.67	(11.59)	43.42
MNPR	6.66	1.33	0.16	2.38	7.32	(7.14)	15.06	(11.91)	38.32

Vincerx Pharma Corporate Management

Raj MBA	VP Manufacturing	Profile
Melissa SPHR	Director Culture	Profile
Karen Quarford	Vice Compliance	Profile
Karen MBA	Vice Compliance	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC